Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;87(11):4124-4139.
doi: 10.1111/bcp.14852. Epub 2021 May 14.

Systematic review of machine learning models for personalised dosing of heparin

Nazanin Falconer  1   2   3 , Ahmad Abdel-Hafez  4 , Ian A Scott  5   6 , Sven Marxen  7 , Stephen Canaris  4 , Michael Barras  1   2
Affiliations
Free article

Systematic review of machine learning models for personalised dosing of heparin

Nazanin Falconer et al. Br J Clin Pharmacol. 2021 Nov.
Free article

Abstract

Aim: To identify and critically appraise studies of prediction models, developed using machine learning (ML) methods, for determining the optimal dosing of unfractionated heparin (UFH).

Methods: Embase, PubMed, CINAHL, Web of Science, International Pharmaceutical Abstracts and IEEE Xplore databases were searched from inception to 31 January 2020 to identify relevant studies using key search terms synonymous with artificial intelligence or ML, 'prediction', 'dose', 'activated partial thromboplastin time (aPTT)' and 'UFH.' Studies had to have used ML methods for developing models that predicted optimal dose of UFH or target therapeutic aPTT levels in the hospital setting. The CHARMS Checklist was used to assess quality and risk of bias of included studies.

Results: Of 8393 retrieved abstracts, 61 underwent full text review and eight studies met inclusion criteria. Four studies described models for predicting aPTT, three studies described models predicting optimal dose of heparin during dialysis and one study described a model that used surrogate outcomes of clotting and bleeding to predict a therapeutic aPTT. Studies varied widely in reporting of study participants, feature characterisation and selection, handling of missing data, sample size calculations and the intended clinical application of the model. Only one study conducted an external validation and no studies evaluated model impacts in clinical practice.

Conclusion: Studies of ML models for UFH dosing are few and none report a model ready for routine clinical use. Existing studies are limited by low methodological quality, inadequate reporting of study factors and absence of external validation and impact analysis.

Keywords: UFH; dose prediction; machine learning algorithm; predictive model; unfractionated heparin.

PubMed Disclaimer

References

REFERENCES

    1. Whiteley WN, Adams HP Jr, Bath PM, et al. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol. 2013;12(6):539-545. https://doi.org/10.1016/s1474-4422(13)70079-6
    1. Hirsh J, Anand SS, Halperin JL, Fuster V. Guide to Anticoagulant Therapy: Heparin - A Statement for Healthcare Professionals from the American Heart Association. Circulation. 2001;103(24):2994-3018.
    1. Hylek EM, Regan S, Henault LE, et al. Challenges to the Effective Use of Unfractionated Heparin in the Hospitalized Management of Acute Thrombosis. Arch Intern Med. 2003;163(5):621-627.
    1. Smythe MA, Priziola J, Dobesh PP, Wirth D, Cuker A, Wittkowsky AK. Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):165-186.
    1. Hyers TM. Management of Venous Thromboembolism: Past, Present, and Future. Arch Intern Med. 2003;163(7):759-768.

Publication types

LinkOut - more resources